| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 4.00K | — |
| Operating expense | — | — |
| Net income | -44.76M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, LYEL returned +44.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -49.5% |
| 1 year | +44.3% |
| 5 years | -95.1% |
| All-time high | $324.80 (Jun 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in LYEL would be worth today ›No. Lyell Immunopharma, Inc. has not paid a dividend in the past 12 months.
Lyell Immunopharma, Inc. stock trades on NASDAQ under the ticker symbol LYEL.
Lyell Immunopharma, Inc. is part of the Healthcare sector.
Lyell Immunopharma, Inc. has a market cap of 380.56M USD, based on the latest quote.
Lyell Immunopharma, Inc. is expected to report earnings around Nov 6, 2026. That date is an estimate and has not been confirmed by the company.
